Where is the live CopyMark page for USPTO serial 74363573?

The live record is at https://getcopymark.com/trademark/74363573. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns MAJOR VALUE?

According to the public USPTO record for serial number 74363573, the listed owner(s) include: MAJOR PHARMACEUTICALS, INC..

What is USPTO serial number 74363573?

Serial number 74363573 is the USPTO application identifier for the mark MAJOR VALUE. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover MAJOR VALUE?

The public record lists International Classes: 005, 010, 035, 042. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: MAJOR VALUE Serial# 74363573 | status 601; last event ABN1 | Trademark Info & Attorney Guidance

Q: What is the current status of MAJOR VALUE?

MAJOR VALUE (74363573) currently shows USPTO status code 601 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MAJOR VALUE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

MAJOR PHARMACEUTICALS, INC.
Chicago, IL
Other trademarks owned by MAJOR PHARMACEUTICALS, INC.

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Martin L. Stern

MARTIN L STERN LAFF, WHITESEL, CONTE & SARET401 N MICHIGAN AVE STE 1700CHICAGO, IL 60611UNITED STATES

Goods and services

Class	Description	Status	First use
005	pharmaceutical preparations; namely, suppositories, allergy capsules and tablets, antihistamines, sedatives, laxatives, antacids, diet control remedies, oral analgesics, vitamins and dietary supplements, cough and cold remedies in the nature of expectorants, drops, lozenges and syrups, capsule and nasal spray decongestants, topical ointments and creams intended for the treatment of burns, dermatological use, antibiotics and eye infections, medicated pre-moistended tissues, anti-nausea and anti-diarrheal remedies, diuretics, anthihypertensive drugs, oral antibiotics, anti-anxiety drugs, anti-epileptic drugs, anti-flammatory drugs, tranquilizers, vasodilators, anti-anginal drugs, anti-coagulants, anti-depressants, psychotropic drugs, anti-arrhythmic drugs, hormones, muscle relaxants, anti-convulsants, and bronchodilators	ABANDONED	—
010	hypodermic syringes, finger splints, condoms, elastic bandages and disposable lancets	ABANDONED	—
035	promoting the sale of the good of others by rendering consulting services to distributors and retailers in the pharmaceutical and medical products field regarding ordering, promoting and selling such products and selling pharmaceutical and medical products of others	ABANDONED	—
042	pharmaceutical and medical products distributorship services	ABANDONED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Nov 27, 1995	ABN1	ABANDONMENT - EXPRESS MAILED	—
Oct 18, 1995	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jan 3, 1994	CNSL	LETTER OF SUSPENSION MAILED	—
Dec 17, 1993	CNEA	EXAMINER'S AMENDMENT MAILED	—
Nov 4, 1993	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
Jun 24, 1993	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 27, 1993	DOCK	ASSIGNED TO EXAMINER	—
May 13, 1993	DOCK	ASSIGNED TO EXAMINER	—

MAJOR VALUE